EP 2238114 A1 20101013 - NOVEL IMIDAZOLINYLMETHYL ARYL SULFONAMIDES
Title (en)
NOVEL IMIDAZOLINYLMETHYL ARYL SULFONAMIDES
Title (de)
NEUARTIGE IMIDAZOLINYLMETHYL-ARYL-SULFONAMIDE
Title (fr)
NOUVEAUX IMIDAZOLINYLMÉTHYLARYLSULFONAMIDES
Publication
Application
Priority
- EP 2009050839 W 20090126
- US 2584208 P 20080204
Abstract (en)
[origin: WO2009098135A1] This invention relates to an alpha- 1 A receptor partial agonist, which is represented by Formula (I) and pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing formula I, methods for their use as therapeutic agents, and methods of preparation thereof.
IPC 8 full level
A61K 31/4178 (2006.01); A61P 13/00 (2006.01); C07D 233/24 (2006.01)
CPC (source: EP)
A61P 13/00 (2017.12); A61P 13/02 (2017.12); A61P 43/00 (2017.12); C07D 233/24 (2013.01)
Citation (search report)
See references of WO 2009098135A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA RS
DOCDB simple family (publication)
WO 2009098135 A1 20090813; AU 2009211505 A1 20090813; BR PI0906640 A2 20190917; CA 2711726 A1 20090813; CN 101925580 A 20101222; EP 2238114 A1 20101013; IL 206612 A0 20101230; JP 2011511025 A 20110407; KR 20100096261 A 20100901; MX 2010007928 A 20100809
DOCDB simple family (application)
EP 2009050839 W 20090126; AU 2009211505 A 20090126; BR PI0906640 A 20090126; CA 2711726 A 20090126; CN 200980102959 A 20090126; EP 09708318 A 20090126; IL 20661210 A 20100624; JP 2010545429 A 20090126; KR 20107016640 A 20090126; MX 2010007928 A 20090126